investordatabase.org

Jeito Capital

jeito.life Direct investor

Jeito Capital is a global investment company focused on biopharma and medical innovation, with a patient-benefit driven approach. It provides significant capital and support to entrepreneurs from clinical development to market access, primarily in Europe and the United States.

Jeito Capital is a venture capital firm headquartered in Paris, France, founded in 2018. It invests directly in companies, from Series A to growth, in biopharma, oncology, autoimmune and ophthalmology. 1.6bn euros under management and 23 portfolio companies, as it reports.

“Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates ground-breaking medical innovation.”

Jeito Capital, own website
Layer
Direct investor
Type
Venture capital
Stage
Series AGrowth
Headquarters
Paris, France
Invests in
Europe, United States
Sectors
Biopharma, Oncology, Autoimmune, Ophthalmology, Cardiology, Obesity, Reproductive medicine, Neuromuscular
Founded
2018
Assets under management
1.6bn euros
Portfolio
23 companies

Team, as Jeito Capital publishes it

  • Rafaèle Tordjman Founder & CEO
  • Sabine Dandiguian Managing Partner
  • Ksenija Pavletic General Partner & Chief Commercial Officer
  • Mehdi Ainouche Partner
  • Annette Clancy Pharma M&A Strategy
  • Claudio Costa-Neto Chief Scientific Officer
  • Karin van Baelen Chief Regulatory Advisor
  • Pascal Touchon Operating Partner
  • Maya Chkaiban Principal
  • Julien Elric Senior Principal
  • Chloé Morlaàs Investor Relations Director
  • Elsa Fernandez Finance Director, Fund

Names and roles exactly as listed on jeito.life. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Jeito Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 1195 · added 2026-08-28 · link last verified 2026-09-06 · confidence high

Similar investors

  • Sofinnova
    Venture capital · Seed – Growth · Paris, France
  • 199 Ventures
    Venture capital · Paris, France
  • ADNEXUS
    Venture capital · Pre-seed – Series A · Paris, France
  • Aglaé Ventures
    Venture capital · Seed – Growth · Paris, France
  • Alven Capital
    Venture capital · Seed – Series A · Paris, France
  • Aster Capital
    Venture capital · Seed – Series B · Paris, France

Listed under